189 related articles for article (PubMed ID: 38609947)
1. Finely tuned ionizable lipid nanoparticles for CRISPR/Cas9 ribonucleoprotein delivery and gene editing.
Im SH; Jang M; Park JH; Chung HJ
J Nanobiotechnology; 2024 Apr; 22(1):175. PubMed ID: 38609947
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of lipid Nanoparticle-Mediated delivery of CRISPR-Cas9 RNP versus mRNA/sgRNA for gene editing in vitro and in vivo.
Walther J; Porenta D; Wilbie D; Seinen C; Benne N; Yang Q; de Jong OG; Lei Z; Mastrobattista E
Eur J Pharm Biopharm; 2024 Mar; 196():114207. PubMed ID: 38325664
[TBL] [Abstract][Full Text] [Related]
3. LNP-mediated delivery of CRISPR RNP for wide-spread in vivo genome editing in mouse cornea.
Mirjalili Mohanna SZ; Djaksigulova D; Hill AM; Wagner PK; Simpson EM; Leavitt BR
J Control Release; 2022 Oct; 350():401-413. PubMed ID: 36029893
[TBL] [Abstract][Full Text] [Related]
4. Lipid-Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Components.
Kazemian P; Yu SY; Thomson SB; Birkenshaw A; Leavitt BR; Ross CJD
Mol Pharm; 2022 Jun; 19(6):1669-1686. PubMed ID: 35594500
[TBL] [Abstract][Full Text] [Related]
5. Biomimetic Mineralization-Based CRISPR/Cas9 Ribonucleoprotein Nanoparticles for Gene Editing.
Li S; Song Z; Liu C; Chen XL; Han H
ACS Appl Mater Interfaces; 2019 Dec; 11(51):47762-47770. PubMed ID: 31773942
[TBL] [Abstract][Full Text] [Related]
6. Development of ionizable lipid nanoparticles and a lyophilized formulation for potent CRISPR-Cas9 delivery and genome editing.
Sun Q; Zhang H; Ding F; Gao X; Zhu Z; Yang C
Int J Pharm; 2024 Mar; 652():123845. PubMed ID: 38266942
[TBL] [Abstract][Full Text] [Related]
7. Methods for CRISPR-Cas as Ribonucleoprotein Complex Delivery In Vivo.
Bykonya AG; Lavrov AV; Smirnikhina SA
Mol Biotechnol; 2023 Feb; 65(2):181-195. PubMed ID: 35322386
[TBL] [Abstract][Full Text] [Related]
8. Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing.
Mout R; Ray M; Yesilbag Tonga G; Lee YW; Tay T; Sasaki K; Rotello VM
ACS Nano; 2017 Mar; 11(3):2452-2458. PubMed ID: 28129503
[TBL] [Abstract][Full Text] [Related]
9. Rationally designed nanoparticle delivery of Cas9 ribonucleoprotein for effective gene editing.
Chae SY; Jeong E; Kang S; Yim Y; Kim JS; Min DH
J Control Release; 2022 May; 345():108-119. PubMed ID: 35247491
[TBL] [Abstract][Full Text] [Related]
10. PEG-Delivered CRISPR-Cas9 Ribonucleoproteins System for Gene-Editing Screening of Maize Protoplasts.
Sant'Ana RRA; Caprestano CA; Nodari RO; Agapito-Tenfen SZ
Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32887261
[TBL] [Abstract][Full Text] [Related]
11. Lipopeptide-Based Nanosome-Mediated Delivery of Hyperaccurate CRISPR/Cas9 Ribonucleoprotein for Gene Editing.
Thach TT; Bae DH; Kim NH; Kang ES; Lee BS; Han K; Kwak M; Choi H; Nam J; Bae T; Suh M; Hur JK; Kim YH
Small; 2019 Nov; 15(46):e1903172. PubMed ID: 31588686
[TBL] [Abstract][Full Text] [Related]
12. Lipofection-mediated genome editing using DNA-free delivery of the Cas9/gRNA ribonucleoprotein into plant cells.
Liu W; Rudis MR; Cheplick MH; Millwood RJ; Yang JP; Ondzighi-Assoume CA; Montgomery GA; Burris KP; Mazarei M; Chesnut JD; Stewart CN
Plant Cell Rep; 2020 Feb; 39(2):245-257. PubMed ID: 31728703
[TBL] [Abstract][Full Text] [Related]
13. Packaging and Uncoating of CRISPR/Cas Ribonucleoproteins for Efficient Gene Editing with Viral and Non-Viral Extracellular Nanoparticles.
Mazurov D; Ramadan L; Kruglova N
Viruses; 2023 Mar; 15(3):. PubMed ID: 36992399
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9 ribonucleoprotein-mediated genome and epigenome editing in mammalian cells.
Bloomer H; Khirallah J; Li Y; Xu Q
Adv Drug Deliv Rev; 2022 Feb; 181():114087. PubMed ID: 34942274
[TBL] [Abstract][Full Text] [Related]
15. Lipid nanoparticles loaded with ribonucleoprotein-oligonucleotide complexes synthesized using a microfluidic device exhibit robust genome editing and hepatitis B virus inhibition.
Suzuki Y; Onuma H; Sato R; Sato Y; Hashiba A; Maeki M; Tokeshi M; Kayesh MEH; Kohara M; Tsukiyama-Kohara K; Harashima H
J Control Release; 2021 Feb; 330():61-71. PubMed ID: 33333121
[TBL] [Abstract][Full Text] [Related]
16. Delivery of CRISPR-Cas12a Ribonucleoprotein Complex for Genome Editing in an Embryogenic Citrus Cell Line.
Fang H; Culver JN; Niedz RP; Qi Y
Methods Mol Biol; 2023; 2653():153-171. PubMed ID: 36995625
[TBL] [Abstract][Full Text] [Related]
17. Versatile modification of the CRISPR/Cas9 ribonucleoprotein system to facilitate in vivo application.
Sun B; Chen H; Gao X
J Control Release; 2021 Sep; 337():698-717. PubMed ID: 34364918
[TBL] [Abstract][Full Text] [Related]
18. CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy.
Rosenblum D; Gutkin A; Kedmi R; Ramishetti S; Veiga N; Jacobi AM; Schubert MS; Friedmann-Morvinski D; Cohen ZR; Behlke MA; Lieberman J; Peer D
Sci Adv; 2020 Nov; 6(47):. PubMed ID: 33208369
[TBL] [Abstract][Full Text] [Related]
19. Cas9 Ribonucleoprotein Complex Delivery: Methods and Applications for Neuroinflammation.
Campbell LA; Richie CT; Maggirwar NS; Harvey BK
J Neuroimmune Pharmacol; 2019 Dec; 14(4):565-577. PubMed ID: 31172397
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of Gene Editing and Base Editing with Therapeutic Ribonucleoproteins through In Vivo Delivery Based on Absorptive Silica Nanoconstruct.
Kim S; Jeong YK; Cho CS; Lee S; Sohn CH; Kim JH; Jeong Y; Jo DH; Bae S; Lee H
Adv Healthc Mater; 2023 Feb; 12(4):e2201825. PubMed ID: 36326169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
